Skip to content
  • Select a Location
  • Search
  • Find a Rep
Menu Close Menu
  • About Us
  • Products
        • Type A Medicated Articles
          • Aivlosin® (Tylvalosin)
          • Deracin™ (Chlortetracycline)
          • Pennchlor® (Chlortetracycline)
          • Pennox® (Oxytetracycline)
          • Neo-Oxy® (Oxytetracycline, Neomycin)
          • Pennitracin® (Bacitracin)
        • Swine Vaccine
          • CircoGard®
          • Circo/MycoGard®
          • MycoGard®
          • MycoGard-1®
          • PRRSGard®
        • Water-soluble Medication
          • Aivlosin® WSG (62.5% w/w Tylvalosin as Tylvalosin Tartrate)
          • Pennchlor® 64 (Chlortetracycline)
          • Pennox® 343 (Oxytetracycline)
        • Injectables Medication
          • Tulissin® 25 (Tulathromycin injection)
          • Tulissin® 100 (Tulathromycin injection)
          • Tenotryl™ (Enrofloxacin)
  • Treatment Directory
  • Tools & Resources
        • Print Rx Labels
          • Blue Bird Labels
          • Product Labels
        • Calculate Dose
          • Water-soluble
          • Feed Medication
        • Discover Solutions
          • Efficiency in Water Solubles
          • Importance of Water Quality
          • Combatting Sow Mortality
          • Put a Stop to SRD
          • Healthcare for Cattle
  • Updates from Pharmgate

Select A Location

  • globe48x48

    Global Site

  • United-States

    United States

  • Canada

    Canada

  • Select a Location
  • Search
  • Find a Rep
Menu

Updates from Pharmgate

Two veterinarians, one vision for effective use of antibiotics

Charlie Francisco, DVM, and Alex Hintz, DVM, represent two generations of veterinarians exposed to swine disease diagnosis, treatment, prevention and regulation in commercial swine operations.

Research
Published on December 4, 2018

Efficacy and safety of adjuvant compositions of a new 1-mL single-dose PCV2/M. hyopneumoniae vaccine (Circo/MycoGard®)

S. Ma1, A. Venegoni1, M. Sheeder2, M. Titus3, L. Kesl3, R. Saltzman3 1Research and Development, Pharmgate Animal Health, Wilmington, NC; 2Struve Labs, Manning, IA; 3Veterinary

Research
Published on September 6, 2018

Field safety and efficacy of a new 1-mL single-dose PCV2/M. hyopneumoniae vaccine (Circo/MycoGard ®) in pigs with severe disease conditions

D. Rosener1, A. Mueller2 , S. Ma1, R. Kaptur1 1Research and Development, Pharmgate Animal Health, Wilmington, NC; 2Swine Services Unlimited Inc., Rice, MN   Introduction Infection

Research
Published on September 6, 2018

Experimental safety and efficacy of a new 1-mL single-dose PCV2/M. hyopneumoniae vaccine (Circo/MycoGard ®)

M. Baarsch1, B. Conarchy1, M. Sheeder2, R. Saltzman3 1Research and Development, Pharmgate Animal Health, Wilmington, NC; 2Struve Labs, Manning, IA; 3Veterinary Resources Inc, Ames, IA

Research
Published on September 5, 2018

Comparative study of the efficacy of Aivlosin® WSG versus Pulmotil® AC and Draxxin® 25 in the control of Swine Respiratory Disease (SRD)

Lechtenberg, K.F.1, Lopez, A2, Berge, A.C.3, Mora, J.2, Hintz, A. 4 1 Midwest Veterinary Services, Nebraska, U.S.; 2 ECO Animal Health, Ltd., London, United Kingdom;

Research
Published on September 5, 2018

PCV2 VLP Vaccines Manufactured using Baculovirus Expression Systems

By Dr. Jeffrey W. Hall, Pharmgate Research Scientist   The family of viruses known as “baculovirus” infects invertebrates, with moth larvae serving as the most

Research
Published on August 28, 2018

Aivlosin® – Your First Choice for SRD and Ileitis Control

By Alexander Hintz, DVM   Tylvalosin is a newer -generation macrolide antibiotic present in both Aivlosin® 62.5% Water Soluble Granules (WSG) and Aivlosin 17% Type

Research
Published on July 23, 2018

Pharmgate announces new appointments.

August 10, 2012 – Pharmgate Animal Health is pleased to announce the appointment of Edward Seed as General Manager. Having started his career in South

Published on August 10, 2012

Pharmgate’s parent company launches successful IPO in China

August 10, 2012 – Jinhe Biotechnology, parent of Pharmgate LLC, successfully completed an initial public offering of 27.23 million A shares of common stock at

Published on August 10, 2012
« Previous 1 … 5 6 7 Next »

Filter

Archives

Pharmgate Animal Health
1800 Sir Tyler Drive
Wilmington, NC 28405
Tel: 1-800-380-6099
Fax: 910-679-8368

Support
customerservice@pharmgate.com

Select a Language
Copyright © 2025 Pharmgate. All rights reserved.
  • Privacy Policy
Follow Pharmgate

This site uses cookies to provide you with a great user experience. By using Pharmgate Animal Health’s website, you accept our use of our Cookies.

USA
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.